CVE-2022-47406: An issue was discovered in the fe_change_pwd (aka Change password for frontend users) extension before 2.0.5,
CVE-2022-47406 is a medium-severity flaw (CVSS 5.4) affecting change password for frontend users. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
An issue was discovered in the fe_change_pwd (aka Change password for frontend users) extension before 2.0.5, and 3.x before 3.0.3, for TYPO3. The extension fails to revoke existing sessions for the current user when the password has been changed.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 5.4 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.5% (top 59%) |
| CISA exploited list | No |
| Weakness | CWE-613 |
| Published | 2022-12-14 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2022-47406?
change password for frontend users: upgrade to 2.0.5, 3.0.3. Exact commands for each OS are on this page.
Is CVE-2022-47406 being exploited?
CVE-2022-47406 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2022-47406 affect?
CVE-2022-47406 affects change password for frontend users. Severity is medium (CVSS 5.4). An issue was discovered in the fe_change_pwd (aka Change password for frontend users) extension before 2.0.5, and 3.x before 3.0.3, for TYPO3. The extension fails to revoke existing sessions for the current user when the password has been c
How urgent is CVE-2022-47406?
Priority 29/100. No elevated risk signals yet.